XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis.
Ji XiaNing MaQian ShiQin-Cheng LiuWei ZhangHui-Jun CaoYi-Kang WangQian-Wen ZhengQian-Zhi NiSheng XuBing ZhuXiao-Song QiuKai DingJing-Yi HuangXin LiangYu ChenYan-Jun XiangXi-Ran ZhangLin QiuWei ChenDong XieXiang WangLingyun LongJing-Jing LiPublished in: The Journal of cell biology (2023)
Metastasis is the main cause of colorectal cancer (CRC)-related death, and the 5-year relative survival rate for CRC patients with distant metastasis is only 14%. X-linked inhibitor of apoptosis (XIAP)-associated factor 1 (XAF1) is a zinc-rich protein belonging to the interferon (IFN)-induced gene family. Here, we report a metastasis-promoting role of XAF1 in CRC by acting as a novel adaptor of valosin-containing protein (VCP). XAF1 facilitates VCP-mediated deubiquitination of the E3 ligase RING finger protein 114 (RNF114), which promotes K48-linked ubiquitination and subsequent degradation of junction plakoglobin (JUP). The XAF1-VCP-RNF114-JUP axis is critical for the migration and metastasis of CRC cells. Moreover, we observe correlations between the protein levels of XAF1, RNF114, and JUP in clinical samples. Collectively, our findings reveal an oncogenic function of XAF1 in mCRC and suggest that the XAF1-VCP-RNF114-JUP axis is a potential therapeutic target for CRC treatment.